Community Investing Ideas

Global Weekly Picks

US$60
FV
89.9% undervalued intrinsic discount
17users have liked this narrative
3users have commented on this narrative
23users have followed this narrative
CA$96.98
34.0% undervalued intrinsic discount
gmalan's Fair Value
Revenue
18.96% p.a.
Profit Margin
20.51%
Future PE
16.63x
Price in 2030
CA$133.9
SEK 101.64
46.1% undervalued intrinsic discount
Mandelman's Fair Value
Revenue
19.24% p.a.
Profit Margin
24%
Future PE
18x
Price in 2030
SEK 156.39
ELTX logo
Elicio Therapeutics

Very Bullish

98% of pancreatic cancer patients in Phase II study generated powerful immune responses to the KRAS antigens. Median T-cell immune response above threshold was 44-fold.Read more

View narrative
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
US$95
91.2% undervalued intrinsic discount
Coward_Nutlick's Fair Value
Profit Margin
21.21%
Future PE
29.38x
Price in 2030
US$0
UK£5
92.9% undervalued intrinsic discount
Double_Bubbler's Fair Value
Revenue
31.98% p.a.
Profit Margin
33%
Future PE
25x
Price in 2030
UK£8.54
US$90.25
28.3% undervalued intrinsic discount
julio's Fair Value
Revenue
7.14% p.a.
Profit Margin
12.05%
Future PE
18x
Price in 2035
US$213.67
US$252.81
95.3% undervalued intrinsic discount
dansberman's Fair Value
Revenue
3.7% p.a.
Profit Margin
25.17%
Future PE
22.5x
Price in 2030
US$368.69
US$52.8
41.2% undervalued intrinsic discount
julio's Fair Value
Revenue
7% p.a.
Profit Margin
7%
Future PE
15x
Price in 2035
US$125.01
US$383.06
8.5% undervalued intrinsic discount
Imperial's Fair Value
Revenue
8.12% p.a.
Profit Margin
28.13%
Future PE
17.94x
Price in 2035
US$1.01k